InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Zante Greg, 首席财务官. Director active across 1 company, notably Viking Therapeutics, Inc.. Aggregated, 18 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €624k. Activity tracked since 28 September 2021. The latest transaction was filed on 28 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Zante Greg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
31,667 股0Common Stock, par value $0.00001 per shareSEC:0001193125-26-324447:0
21,217 股@ US$33.47040.017% mcap56.2% 占其流量Common Stock, par value $0.00001 per shareSEC:0001193125-26-324447:1
41,000 股0Common Stock, par value $0.00001 per shareSEC:0001193125-26-003116:0
11,117 股0Common Stock, par value $0.00001 per shareSEC:0001193125-25-254298:0
7,667 股0Common Stock, par value $0.00001 per shareSEC:0000950170-25-093792:0
44,533 股0Common Stock, par value $0.00001 per shareSEC:0000950170-25-002485:0
12,750 股@ US$7.7718.4% 占其流量Common Stock, par value $0.00001 per shareSEC:0000950170-24-117885:0
6,667 股0Common Stock, par value $0.00001 per shareSEC:0000950170-24-088538:0
4,249 股@ US$4.683.7% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-24-005522:0
31,667 股0Common Stock, par value $0.00001 per shareSEC:0001209191-24-005116:0
31,667 股0Common Stock, par value $0.00001 per shareSEC:0001209191-24-004231:0
28,334 股0Common Stock, par value $0.00001 per shareSEC:0001209191-24-000929:0
7,500 股@ US$13.0718.0% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-23-024722:0
3,242 股@ US$7.774.6% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-23-024227:0
32,000 股@ US$8.5250.0% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-23-022398:0
20,233 股0Common Stock, par value $0.00001 per shareSEC:0001209191-23-001343:0
3,097 股@ US$4.881.2% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-22-001988:0
6,667 股0Common Stock, par value $0.00001 per shareSEC:0001209191-21-058246:0
18 条申报中的 18 条
About Zante Greg
ZANTE GREG is Directeur Financier at Viking Therapeutics, Inc. He appears in 16 filings in total, and across the recent sample of 16 filings, both buy and sell amounts are 0 EUR, with filings observed between 2021-09-30 and 2026-01-05. The most frequent transaction nature is Attribution.
